Fertility warning
This medicine may affect fertility.
Leaflet LYNPARZA 150mg film-coated tablets
Precautions:
Cytotoxic / special handling
Handle with special care.
Contraception required
Effective contraception is required during treatment.
Contraindicated during breastfeeding
Do not use this medicine while breastfeeding.
Contraindicated during pregnancy
Do not use this medicine during pregnancy.
Hepatotoxicity
This medicine may affect the liver.
Major drug interactions
This medicine may have important interactions with other medicines.
Myelosuppression / agranulocytosis
This medicine may lower blood cell counts.
Additional monitoring
This medicine is subject to additional monitoring.
Requires periodic laboratory tests
Periodic laboratory tests may be required during treatment.
Severe skin reactions
Stop taking the medicine and seek urgent medical help if a severe rash occurs.
Olaparib is a medication used for the treatment of certain types of cancer, such as ovarian, breast, or prostate cancer, associated with BRCA gene mutations. It is a poly(ADP-ribose) polymerase (PARP) inhibitor that interferes with DNA repair in cancer cells, leading to their death.
The medication is taken orally, usually twice daily, as directed by your doctor. It is important to follow the treatment regimen and undergo regular check-ups to monitor effectiveness and potential side effects.
Side effects may include nausea, fatigue, anemia, diarrhea, or, in rare cases, myelodysplastic syndrome.
Patients should inform their doctor about any other medications being used or pre-existing conditions to ensure the safe use of olaparib.
The medication is taken orally, usually twice daily, as directed by your doctor. It is important to follow the treatment regimen and undergo regular check-ups to monitor effectiveness and potential side effects.
Side effects may include nausea, fatigue, anemia, diarrhea, or, in rare cases, myelodysplastic syndrome.
Patients should inform their doctor about any other medications being used or pre-existing conditions to ensure the safe use of olaparib.
Official documents
- Added to database:
- 09/01/2015
- Source record updated:
- 19/02/2026
General data about LYNPARZA 150mg
- Substance:
- olaparib
- Date of latest medicines list:
- 01-06-2026
- Product code:
- W64661001
- Concentration:
- 150mg
- Pharmaceutical form:
- film-coated tablets
- Quantity:
- 56
- Product type:
- Original
- Price:
- 10886.28 RON
- Prescription status:
- P-RF — Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.
Pharmaceutical forms available for olaparib
Concentrations available for olaparib
- 100mg
- 150mg
- 50mg